KELSEY BRENNAN: Open Payments
NPI 1114606399 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,318 in 163 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,116 · 2025 $3,318
Food & beverage: $3,313Education: $5
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 28 | $596 |
| ABBVIE INC. | 17 | $387 |
| Botanix SB Inc | 18 | $361 |
| Regeneron Healthcare Solutions, Inc. | 11 | $324 |
| PFIZER INC. | 15 | $305 |
| Galderma Laboratories, L.P. | 19 | $247 |
| Janssen Biotech, Inc. | 9 | $196 |
| Arcutis Biotherapeutics, Inc. | 13 | $152 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $119 |
| LEO Pharma Inc. | 5 | $117 |
Products named: OPZELURA, DUPIXENT, SOFDRA, CIBINQO, RINVOQ, TREMFYA, AKLIEF, SKYRIZI.
Industry payments across CT — which companies pay providers there.
